Cargando…

Structure–Activity Relationship Development Efforts towards Peripherally Selective Analogs of the Cannabinoid Receptor Partial Agonist BAY 59-3074

Selective modulation of peripheral cannabinoid receptors (CBRs) has potential therapeutic applications in medical conditions, including obesity, diabetes, liver diseases, GI disorders and pain. While there have been considerable efforts to produce selective antagonists or full agonists of CBRs, ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amato, George, Vasukuttan, Vineetha, Harris, Danni, Laudermilk, Lucas, Lucitti, Jennifer, Runyon, Scott, Maitra, Rangan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457575/ https://www.ncbi.nlm.nih.gov/pubmed/36080443 http://dx.doi.org/10.3390/molecules27175672

Ejemplares similares

Distribution of respiratory viruses: Evaluation of multiplex PCR results of 3074 patients
por: Zeytinli, Ulku Oral, et al.
Publicado: (2022)

miR-3074-3p promotes myoblast differentiation by targeting Cav1
por: Lee, Bora, et al.
Publicado: (2020)

Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain
por: Marchalant, Y, et al.
Publicado: (2009)

Saturated Cannabinoids: Update on Synthesis Strategies and Biological Studies of These Emerging Cannabinoid Analogs
por: Docampo-Palacios, Maite L., et al.
Publicado: (2023)

Therapeutic Efficacy of Novel HDAC Inhibitors SPA3052 and SPA3074 against Intestinal Inflammation in a Murine Model of Colitis
por: Yoon, Ji-In, et al.
Publicado: (2022)

Enhanced effects of antagomiR-3074-3p-conjugated PEI-AuNPs on the odontogenic differentiation by targeting FKBP9
por: Jiang, Tao, et al.
Publicado: (2023)

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022)

Apoptosis-promoting properties of miR-3074-5p in MC3T3-E1 cells under iron overload conditions
por: Feng, Yi, et al.
Publicado: (2021)

Cannabinoids: A New Group of Agonists of PPARs
por: Sun, Yan, et al.
Publicado: (2007)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2) receptor
por: Patel, Monica, et al.
Publicado: (2023)

Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism
por: Gavryushov, Sergei, et al.
Publicado: (2023)

Stacking regularization in analogy-based software effort estimation
por: Kaushik, Anupama, et al.
Publicado: (2022)

High hopes for cannabinoid agonists in the treatment of rheumatic diseases
por: Staunton, Caroline A, et al.
Publicado: (2014)

Climate-change refugia in the sheltered bays of Palau: analogs of future reefs
por: Woesik, Robert, et al.
Publicado: (2012)

The Impact of Targeted Trap–Neuter–Return Efforts in the San Francisco Bay Area
por: Spehar, Daniel D., et al.
Publicado: (2020)

Synergistic Antibacterial Effect of Phage pB3074 in Combination with Antibiotics Targeting Cell Wall against Multidrug-Resistant Acinetobacter baumannii In Vitro and Ex Vivo
por: Luo, Jun, et al.
Publicado: (2023)

Cannabinoid Receptor 1 Agonist ACEA and Cannabinoid Receptor 2 Agonist GW833972A Attenuates Cell-Mediated Immunity by Different Biological Mechanisms
por: Takheaw, Nuchjira, et al.
Publicado: (2023)

Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069
por: Orsi, Douglas L., et al.
Publicado: (2022)

Mechanistic origin of partial agonism of tetrahydrocannabinol for cannabinoid receptors
por: Dutta, Soumajit, et al.
Publicado: (2022)

Correction to “Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069”
por: Orsi, Douglas L., et al.
Publicado: (2022)

Inhibition of retinoic acid receptor α phosphorylation represses the progression of triple-negative breast cancer via transactivating miR-3074-5p to target DHRS3
por: Lou, Siyue, et al.
Publicado: (2021)

Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor
por: Zagzoog, Ayat, et al.
Publicado: (2021)

Differentiable PAC–Bayes Objectives with Partially Aggregated Neural Networks
por: Biggs, Felix, et al.
Publicado: (2021)

Synthetic Cannabinoid Receptor Agonists Detection Using Fluorescence Spectral Fingerprinting
por: May, Benedict, et al.
Publicado: (2019)

New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists
por: Faúndez-Parraguez, Manuel, et al.
Publicado: (2021)

Docking and Molecular Dynamic Investigations of Phenylspirodrimanes as Cannabinoid Receptor-2 Agonists
por: Omar, Abdelsattar M., et al.
Publicado: (2022)

Influence of the Synthetic Cannabinoid Agonist on Normal and Inflamed Cartilage: An In Vitro Study
por: Shang, Jiangyinzi, et al.
Publicado: (2023)

PM287. Mixtures of opioid receptor agonists and cannabinoid receptor agonists: enhanced antinociception without abuse liability
por: France, Charles P, et al.
Publicado: (2016)

Abnormalities in Dynamic Brain Activity Caused by Mild Traumatic Brain Injury Are Partially Rescued by the Cannabinoid Type-2 Receptor Inverse Agonist SMM-189
por: Liu, Yu, et al.
Publicado: (2017)

In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonist
por: Burstein, Sumner H, et al.
Publicado: (2013)

Cannabinoid agonist rescues learning and memory after a traumatic brain injury
por: Arain, Marium, et al.
Publicado: (2015)

Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex
por: Diez-Alarcia, Rebeca, et al.
Publicado: (2016)

Assessment of Cannabinoids Agonist and Antagonist in Invasion Potential of K562 Cancer Cells
por: Gholizadeh, Fatemeh, et al.
Publicado: (2019)

Fluoroscopic Characterization of Colonic Dysmotility Associated to Opioid and Cannabinoid Agonists in Conscious Rats
por: Díaz-Ruano, Susana, et al.
Publicado: (2019)

Differential activation of G protein‐mediated signaling by synthetic cannabinoid receptor agonists
por: Sachdev, Shivani, et al.
Publicado: (2020)

Fourth generation of synthetic cannabinoid receptor agonists: a summary on the latest insights
por: Malaca, Sara, et al.
Publicado: (2021)

Bayes or not Bayes, is this the question?
por: K. Hackenberger, Branimir
Publicado: (2019)

Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist
por: Wang, Yu-Hua, et al.
Publicado: (2018)

Expression of cannabinoid 1 and, 2 receptors and the effects of cannabinoid 1 and, 2 receptor agonists on detrusor overactivity associated with bladder outlet obstruction in rats
por: Kim, Sung Dae, et al.
Publicado: (2017)

Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction
por: Jeon, Posung, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_r2s6s6ar1i5vjq1sobgsufeorl